Management of human immunodeficiency virus infection in pregnancy

@article{citeulike:1116290, abstract = {The HIV global epidemic is having a devastating effect on women of reproductive age; women aged 15-24 years are 2.5 times more likely to be infected than young men in the same age group. Further, mother-to-child transmission (MTCT) accounts for almost two-thirds of the new infections that occur in children world-wide, annually. MTCT of HIV-1 varies widely and is dependent on obstetric practices, mode of delivery, breastfeeding, and the level of the viral load in the mother. Antiretroviral therapy (ARV) in pregnancy is prescribed for two main reasons: (i) women who need ARV medication for their own health; (ii) women who do not need treatment, or do not have access to treatment are offered prophylaxis to prevent MTCT, using one of a number of ARV regimens known to be effective. HIV infection is also associated with significant maternal morbidity and mortality. Clinicians caring for HIV-infected women need to update their knowledge continuously to provide optimal care.}, author = {Moodley, J. and Moodley, D. }, booktitle = {HIV in Obstetrics \& Gynaecology}, citeulike-article-id = {1116290}, doi = {10.1016/j.bpobgyn.2004.10.007}, journal = {Best Practice \& Research Clinical Obstetrics \& Gynaecology}, keywords = {125}, month = {April}, number = {2}, pages = {169--183}, posted-at = {2007-02-21 13:57:26}, priority = {2}, title = {Management of human immunodeficiency virus infection in pregnancy}, url = {http://dx.doi.org/10.1016/j.bpobgyn.2004.10.007}, volume = {19}, year = {2005} }

TY - JOUR ID - citeulike:1116290 L3 - citeulike-article-id:1116290 TI - Management of human immunodeficiency virus infection in pregnancy T2 - HIV in Obstetrics & Gynaecology JF - Best Practice & Research Clinical Obstetrics & Gynaecology VL - 19 IS - 2 SP - 169 EP - 183 N2 - The HIV global epidemic is having a devastating effect on women of reproductive age; women aged 15-24 years are 2.5 times more likely to be infected than young men in the same age group. Further, mother-to-child transmission (MTCT) accounts for almost two-thirds of the new infections that occur in children world-wide, annually. MTCT of HIV-1 varies widely and is dependent on obstetric practices, mode of delivery, breastfeeding, and the level of the viral load in the mother. Antiretroviral therapy (ARV) in pregnancy is prescribed for two main reasons: (i) women who need ARV medication for their own health; (ii) women who do not need treatment, or do not have access to treatment are offered prophylaxis to prevent MTCT, using one of a number of ARV regimens known to be effective. HIV infection is also associated with significant maternal morbidity and mortality. Clinicians caring for HIV-infected women need to update their knowledge continuously to provide optimal care. KW - 125 AU - Moodley, J AU - Moodley, D PY - 2005/04// UR - http://dx.doi.org/10.1016/j.bpobgyn.2004.10.007 ER -